Lupin Limited — Updates, 01-07-2026: Press Release
01-07-2026 | 09:53 pm
01-07-2026 | 09:53 pm
Lupin's Somerset manufacturing facility received a satisfactory Voluntary Action Indicated (VAI) classification from the U.S. FDA. This positive EIR confirms strong quality and compliance, supporting continued market access and operations.
No comments yet. Be the first to comment!
